Actively Recruiting
Resilience to Antibiotic-induced Obesogenic Microbiota: Discovering Mechanism of Microbiota Modulation
Led by Turku University Hospital · Updated on 2025-05-16
125
Participants Needed
1
Research Sites
290 weeks
Total Duration
On this page
Sponsors
T
Turku University Hospital
Lead Sponsor
L
Lallemand Health Solutions
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aim is to study whether the microbiota of children who are exposed to antibiotics at birth could be modified by synbiotic supplement and thereby reduce the risk of obesity, chronic diseases and respiratory tract infections. A total of 125 mother-child pairs will be recruited in this randomized, double-blind, placebo-controlled study. Infants are randomized to receive either a synbiotic supplement or a placebo for 2 months, after which their growth and morbidity will be monitored at the research clinic for 2 years.
CONDITIONS
Official Title
Resilience to Antibiotic-induced Obesogenic Microbiota: Discovering Mechanism of Microbiota Modulation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women and their newborn infants who receive antibiotic treatment at delivery
You will not qualify if you...
- Chorioamnionitis
- Pre-eclampsia and hepatogestosis
- Suspected malformation or serious condition of the fetus or neonate
- Serious infection or other conditions preventing breast milk feeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Paediatrics and Adolescent Medicine, Turku University Hospital and University of Turku
Turku, Valitse Maakunta., Finland, 20780
Actively Recruiting
Research Team
P
Paula Tähtinen, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here